US Patent Issued to CASTLE BIOSCIENCES on July 22 for "Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma" (Texas, Arizona Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,948, issued on July 22, was assigned to CASTLE BIOSCIENCES INC. (Friendswood, Texas).

"Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma" was invented by Robert Willis Cook (Houston), Derek Maetzold (Friendswood, Texas) and Kristen Oeschlager (Phoenix).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention as disclosed herein in encompasses a method for predicting the risk of metastasis of a primary cutaneous melanoma tumor, the method encompassing measuring the gene-expression levels of at least eight genes selected from a specific gene set in a sample taken from the primary cutaneous melanoma tumor; determining a ...